Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor.

Benza RL, Doyle M, Lasorda D, Parikh KS, Correa-Jaque P, Badie N, Ginn G, Airhart S, Franco V, Kanwar MK, Murali S, Raina A, Agarwal R, Rajagopal S, White J, Biederman R.

Chest. 2019 Jun 29. pii: S0012-3692(19)31238-3. doi: 10.1016/j.chest.2019.06.010. [Epub ahead of print]

PMID:
31265832
2.

Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.

Woo XY, Srivastava A, Graber JH, Yadav V, Sarsani VK, Simons A, Beane G, Grubb S, Ananda G, Liu R, Stafford G, Chuang JH, Airhart SD, Karuturi RKM, George J, Bult CJ.

BMC Med Genomics. 2019 Jul 1;12(1):92. doi: 10.1186/s12920-019-0551-2.

3.

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.

Berlow NE, Rikhi R, Geltzeiler M, Abraham J, Svalina MN, Davis LE, Wise E, Mancini M, Noujaim J, Mansoor A, Quist MJ, Matlock KL, Goros MW, Hernandez BS, Doung YC, Thway K, Tsukahara T, Nishio J, Huang ET, Airhart S, Bult CJ, Gandour-Edwards R, Maki RG, Jones RL, Michalek JE, Milovancev M, Ghosh S, Pal R, Keller C.

BMC Cancer. 2019 Jun 17;19(1):593. doi: 10.1186/s12885-019-5681-6.

4.

Factors that influence response classifications in chemotherapy treated patient-derived xenografts (PDX).

Malcolm JE, Stearns TM, Airhart SD, Graber JH, Bult CJ.

PeerJ. 2019 Mar 28;7:e6586. doi: 10.7717/peerj.6586. eCollection 2019.

5.

Use of an implantable wireless pulmonary pressure monitor during transition of therapy in pulmonary arterial hypertension.

Airhart S, Verlinden N, Badie N, Raina A, Benza R.

J Heart Lung Transplant. 2019 Feb;38(2):227-230. doi: 10.1016/j.healun.2018.11.011. Epub 2018 Nov 24. No abstract available.

PMID:
30691597
6.

Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry.

Khariton Y, Airhart S, Salisbury AC, Spertus JA, Gosch KL, Grantham JA, Karmpaliotis D, Moses JW, Nicholson WJ, Cohen DJ, Lombardi W, Sapontis J, McCabe JM.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2276-2283. doi: 10.1016/j.jcin.2018.07.058.

7.

Right ventricular afterload predicts long-term transition from parenteral to oral treprostinil in pulmonary arterial hypertension.

Maestas T, Hansen LM, Vanderpool RR, Desai AA, Airhart S, Knapp SM, Cohen A, Feldman J, Rischard FP.

Pulm Circ. 2018 Oct-Dec;8(4):2045894018797270. doi: 10.1177/2045894018797270. Epub 2018 Aug 20.

8.

Telemedicine in the Intensive Care Unit: Improved Access to Care at What Cost?

Binder WJ, Cook JL, Gramze N, Airhart S.

Crit Care Nurs Clin North Am. 2018 Jun;30(2):289-296. doi: 10.1016/j.cnc.2018.02.010. Epub 2018 Mar 21. Review.

PMID:
29724446
9.

New Therapeutic Target in Heart Failure: Achieving and Maintaining Normokalemia.

Sweitzer NK, Airhart S.

Circulation. 2018 Mar 27;137(13):1331-1333. doi: 10.1161/CIRCULATIONAHA.118.033854. No abstract available.

PMID:
29581363
10.

Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.

Long Q, Lin TY, Huang Y, Li X, Ma AH, Zhang H, Carney R, Airhart S, Lam KS, deVere White RW, Pan CX, Li Y.

Nanomedicine. 2018 Apr;14(3):789-799. doi: 10.1016/j.nano.2017.12.014. Epub 2018 Jan 6.

11.

COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin.

Wang F, Zhang H, Ma AH, Yu W, Zimmermann M, Yang J, Hwang SH, Zhu D, Lin TY, Malfatti M, Turteltaub KW, Henderson PT, Airhart S, Hammock BD, Yuan J, de Vere White RW, Pan CX.

Mol Cancer Ther. 2018 Feb;17(2):474-483. doi: 10.1158/1535-7163.MCT-16-0818. Epub 2017 Dec 28.

12.

An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.

Airhart SE, Shireman LM, Risler LJ, Anderson GD, Nagana Gowda GA, Raftery D, Tian R, Shen DD, O'Brien KD.

PLoS One. 2017 Dec 6;12(12):e0186459. doi: 10.1371/journal.pone.0186459. eCollection 2017.

13.

Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy.

Wang M, Yao LC, Cheng M, Cai D, Martinek J, Pan CX, Shi W, Ma AH, De Vere White RW, Airhart S, Liu ET, Banchereau J, Brehm MA, Greiner DL, Shultz LD, Palucka K, Keck JG.

FASEB J. 2018 Mar;32(3):1537-1549. doi: 10.1096/fj.201700740R. Epub 2018 Jan 3.

14.

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma.

Bharathy N, Svalina MN, Settelmeyer TP, Cleary MM, Berlow NE, Airhart SD, Xiang S, Keck J, Hayden JB, Shern JF, Mansoor A, Lathara M, Srinivasa G, Langenau DM, Keller C.

Oncotarget. 2017 Jun 16;8(38):62976-62983. doi: 10.18632/oncotarget.18520. eCollection 2017 Sep 8.

15.

The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.

Zeng SX, Zhu Y, Ma AH, Yu W, Zhang H, Lin TY, Shi W, Tepper CG, Henderson PT, Airhart S, Guo JM, Xu CL, deVere White RW, Pan CX.

Clin Cancer Res. 2017 Nov 1;23(21):6580-6591. doi: 10.1158/1078-0432.CCR-17-0033. Epub 2017 Aug 14.

16.

Modeling of Patient-Derived Xenografts in Colorectal Cancer.

Katsiampoura A, Raghav K, Jiang ZQ, Menter DG, Varkaris A, Morelli MP, Manuel S, Wu J, Sorokin AV, Rizi BS, Bristow C, Tian F, Airhart S, Cheng M, Broom BM, Morris J, Overman MJ, Powis G, Kopetz S.

Mol Cancer Ther. 2017 Jul;16(7):1435-1442. doi: 10.1158/1535-7163.MCT-16-0721. Epub 2017 May 3.

17.

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Dobrolecki LE, Airhart SD, Alferez DG, Aparicio S, Behbod F, Bentires-Alj M, Brisken C, Bult CJ, Cai S, Clarke RB, Dowst H, Ellis MJ, Gonzalez-Suarez E, Iggo RD, Kabos P, Li S, Lindeman GJ, Marangoni E, McCoy A, Meric-Bernstam F, Piwnica-Worms H, Poupon MF, Reis-Filho J, Sartorius CA, Scabia V, Sflomos G, Tu Y, Vaillant F, Visvader JE, Welm A, Wicha MS, Lewis MT.

Cancer Metastasis Rev. 2016 Dec;35(4):547-573. doi: 10.1007/s10555-016-9653-x. Review.

18.

Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice.

Zimmermann M, Wang SS, Zhang H, Lin TY, Malfatti M, Haack K, Ognibene T, Yang H, Airhart S, Turteltaub KW, Cimino GD, Tepper CG, Drakaki A, Chamie K, de Vere White R, Pan CX, Henderson PT.

Mol Cancer Ther. 2017 Feb;16(2):376-387. doi: 10.1158/1535-7163.MCT-16-0381. Epub 2016 Nov 30.

19.

Relative prosthesis-patient mismatch after transcatheter aortic valve replacement: The impact of morbid obesity.

Airhart S, Medvedev I, Dean LS.

Catheter Cardiovasc Interv. 2017 Aug 1;90(2):341-345. doi: 10.1002/ccd.26721. Epub 2016 Aug 27.

PMID:
27566959
20.

Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer.

Lin TY, Li Y, Liu Q, Chen JL, Zhang H, Lac D, Zhang H, Ferrara KW, Wachsmann-Hogiu S, Li T, Airhart S, deVere White R, Lam KS, Pan CX.

Biomaterials. 2016 Oct;104:339-51. doi: 10.1016/j.biomaterials.2016.07.026. Epub 2016 Jul 22.

21.

Ketones Step to the Plate: A Game Changer for Metabolic Remodeling in Heart Failure?

Kolwicz SC Jr, Airhart S, Tian R.

Circulation. 2016 Feb 23;133(8):689-91. doi: 10.1161/CIRCULATIONAHA.116.021230. Epub 2016 Jan 27. No abstract available.

22.

A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies.

Hooper JE, Cantor EL, Ehlen MS, Banerjee A, Malempati S, Stenzel P, Woltjer RL, Gandour-Edwards R, Goodwin NC, Yang Y, Kaur P, Bult CJ, Airhart SD, Keller C.

Sarcoma. 2015;2015:826124. doi: 10.1155/2015/826124. Epub 2015 Nov 30.

23.

A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot Study.

Airhart S, Cade WT, Jiang H, Coggan AR, Racette SB, Korenblat K, Spearie CA, Waller S, O'Connor R, Bashir A, Ory DS, Schaffer JE, Novak E, Farmer M, Waggoner AD, Dávila-Román VG, Javidan-Nejad C, Peterson LR.

J Clin Endocrinol Metab. 2016 Feb;101(2):504-12. doi: 10.1210/jc.2015-3292. Epub 2015 Dec 10.

24.

Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.

Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW.

PLoS One. 2015 Aug 13;10(8):e0134346. doi: 10.1371/journal.pone.0134346. eCollection 2015.

25.

Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform.

Gandara DR, Mack PC, Bult C, Li T, Lara PN Jr, Riess JW, Astrow SH, Gandour-Edwards R, Cooke DT, Yoneda KY, Moore EH, Pan CX, Burich RA, David EA, Keck JG, Airhart S, Goodwin N, de Vere White RW, Liu ET.

Clin Lung Cancer. 2015 May;16(3):165-72. doi: 10.1016/j.cllc.2015.03.001. Epub 2015 Mar 18.

26.
27.

A rodent-human hybrid containing Xq24-qter translocated to a hamster chromosome expresses the Xq27 folate-sensitive fragile site.

Nussbaum RL, Airhart SD, Ledbetter DH.

Am J Med Genet. 1986 Jan-Feb;23(1-2):457-66.

PMID:
2937300
28.

Caffeine enhances fragile (X) expression in somatic cell hybrids.

Ledbetter DH, Airhart SD, Nussbaum RL.

Am J Med Genet. 1986 Jan-Feb;23(1-2):445-55.

PMID:
2937299
29.

Somatic cell hybrid studies of fragile (X) expression in a carrier female and transmitting male.

Ledbetter DH, Airhart SD, Nussbaum RL.

Am J Med Genet. 1986 Jan-Feb;23(1-2):429-43.

PMID:
2937298
31.

Fragile (X) expression induced by FUdR is transient and inversely related to levels of thymidylate synthase activity.

Cantú ES, Nussbaum RL, Airhart SD, Ledbetter DH.

Am J Hum Genet. 1985 Sep;37(5):947-55.

32.

Human chromosomal assignments for 14 argininosuccinate synthetase pseudogenes: cloned DNAs as reagents for cytogenetic analysis.

Su TS, Nussbaum RL, Airhart S, Ledbetter DH, Mohandas T, O'Brien WE, Beaudet AL.

Am J Hum Genet. 1984 Sep;36(5):954-64.

33.

New chromosomal syndrome: Miller-Dieker syndrome and monosomy 17p13.

Stratton RF, Dobyns WB, Airhart SD, Ledbetter DH.

Hum Genet. 1984;67(2):193-200.

PMID:
6745939
34.

Expression of the fragile (X) chromosome in an interspecific somatic cell hybrid.

Nussbaum RL, Airhart SD, Ledbetter DH.

Hum Genet. 1983;64(2):148-50.

PMID:
6885049
35.

Chromosome 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases.

Ledbetter DH, Mascarello JT, Riccardi VM, Harper VD, Airhart SD, Strobel RJ.

Am J Hum Genet. 1982 Mar;34(2):278-85.

36.

Deletions of chromosome 15 as a cause of the Prader-Willi syndrome.

Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD.

N Engl J Med. 1981 Feb 5;304(6):325-9. No abstract available.

PMID:
7442771

Supplemental Content

Loading ...
Support Center